In HBV-related HCC, CD4+ cytotoxic T cell was progressively deficit as HCC progressed, and decreased number and/or functional impairment of CD4+ cytotoxic T cells was associated with poor clinical outcomes [54]. This evidence concerns the gene CD4 and hepatocellular carcinoma.